A detailed history of Eagle Rock Investment Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Eagle Rock Investment Company, LLC holds 3,662 shares of LLY stock, worth $2.74 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
3,662
Previous 3,664 0.05%
Holding current value
$2.74 Million
Previous $3.32 Million 2.2%
% of portfolio
0.56%
Previous 0.61%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$772.14 - $960.02 $1,544 - $1,920
-2 Reduced 0.05%
3,662 $3.24 Million
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $68,137 - $85,449
-94 Reduced 2.5%
3,664 $3.32 Million
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $283,663 - $379,502
-479 Reduced 11.31%
3,758 $2.92 Million
Q4 2023

Jan 12, 2024

SELL
$525.19 - $619.13 $393,892 - $464,347
-750 Reduced 15.04%
4,237 $2.47 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $191,268 - $263,692
-440 Reduced 8.11%
4,987 $2.68 Million
Q2 2023

Jul 19, 2023

SELL
$350.74 - $468.98 $136,788 - $182,902
-390 Reduced 6.7%
5,427 $2.55 Million
Q1 2023

Apr 10, 2023

SELL
$310.63 - $364.82 $504,152 - $592,102
-1,623 Reduced 21.81%
5,817 $2 Million
Q4 2022

Jan 25, 2023

SELL
$321.55 - $374.67 $112,542 - $131,134
-350 Reduced 4.49%
7,440 $0
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $44,472 - $50,680
-150 Reduced 1.89%
7,790 $2.52 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $209,047 - $245,452
-750 Reduced 8.63%
7,940 $2.57 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $147,854 - $183,745
-630 Reduced 6.76%
8,690 $2.49 Million
Q4 2021

Feb 17, 2022

BUY
$224.85 - $279.04 $2.1 Million - $2.6 Million
9,320 New
9,320 $2.57 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Eagle Rock Investment Company, LLC Portfolio

Follow Eagle Rock Investment Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.